These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9263650)

  • 1. New or developing antihypertensive agents.
    Evans RR; DiPette DJ
    Curr Opin Cardiol; 1997 Jul; 12(4):382-8. PubMed ID: 9263650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do we need a new strategy in hypertension treatment?].
    Beaufils M
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):630-5. PubMed ID: 12555469
    [No Abstract]   [Full Text] [Related]  

  • 6. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five decades of antihypertensive treatment: the unresolved issues.
    Julius S
    J Hypertens Suppl; 2000 Jul; 18(3):S3-7. PubMed ID: 10952081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive medications and renal disease.
    Andrews L; Gibbs MA
    Nephrol Nurs J; 2002 Aug; 29(4):379-82. PubMed ID: 12224374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.
    Peppard WJ; Johnston CJ; Urmanski AM
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):83-99. PubMed ID: 18251666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazide diuretics in the treatment of hypertension: an update.
    Salvetti A; Ghiadoni L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S25-9. PubMed ID: 16565243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characteristics of investigational and recently approved agents for the treatment of HIV.
    Kiser JJ
    Curr Opin HIV AIDS; 2008 May; 3(3):330-41. PubMed ID: 19372987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension: a review of therapeutic options.
    Carter BL
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):34-44. PubMed ID: 12971591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular pharmacology: opportunities for intervention.
    Keiser J
    Clin Pharmacol Ther; 2009 Aug; 86(2):124-6. PubMed ID: 19621004
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
    Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
    Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapies for treating hypertension: what every physician should know.
    Shah MK; Hugghins SY; Champion HC; Bivalacqua TJ
    J La State Med Soc; 2000 Jul; 152(7):334-44. PubMed ID: 10986845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antihypertensive effects of angiotensin II receptor antagonists.
    Burnier M; Brunner HR
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S278-82. PubMed ID: 10201883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.